Werewolf Therapeutics
is a Massachusetts-based biopharmaceutical company that researches, develops, and commercializes immune therapeutics for the treatment of cancer... Read moreWerewolf Therapeutics
is a Massachusetts-based biopharmaceutical company that researches, develops, and commercializes immune therapeutics for the treatment of cancer... Read more
News
Mar 27, 2026
Seeking Alpha
Werewolf Therapeutics: Werewolf Therapeutics GAAP EPS of -$0.20 beats by $0.14
Mar 27, 2026
GlobeNewswire
Press Release: Werewolf Therapeutics : Werewolf Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
Feb 24, 2026
Investing.com
Werewolf Therapeutics: Werewolf Therapeutics explores strategic alternatives including sale
Feb 24, 2026
FierceBiotechIT
Werewolf Therapeutics: Werewolf weighs sale or merger as cash reserves whimper
Dec 18, 2025
GlobalNewswire
Press Release: Werewolf Therapeutics : Werewolf Therapeutics Announces Pipeline and Business Updates
Dec 18, 2025
RTTNews
Werewolf Therapeutics: Werewolf Reveals Interim Data For Lead Candidates, Shares Slip
Nov 04, 2025
Marketscreener
Werewolf Therapeutics: Werewolf Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
Oct 11, 2025
Pharmabiz
Werewolf Therapeutics: Werewolf Therapeutics gets US FDA fast track designation for its investigational therapy WTX124 for treatment of cancer
Oct 03, 2025
Benzinga
Werewolf Therapeutics: Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's (SITC) 40th Annual Meeting
Sep 07, 2025
Americanbankingnews
Werewolf Therapeutics: Brokers Issue Forecasts for HOWL Q1 Earnings
Werewolf Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10